| Literature DB >> 28900390 |
Silvia Pellegrini1, Sara Palumbo2, Caterina Iofrida3, Erika Melissari2, Giuseppina Rota4, Veronica Mariotti1, Teresa Anastasio1, Andrea Manfrinati5, Rino Rumiati6, Lorella Lotto6, Michela Sarlo7, Pietro Pietrini8.
Abstract
Moral behavior has been a key topic of debate for philosophy and psychology for a long time. In recent years, thanks to the development of novel methodologies in cognitive sciences, the question of how we make moral choices has expanded to the study of neurobiological correlates that subtend the mental processes involved in moral behavior. For instance, in vivo brain imaging studies have shown that distinct patterns of brain neural activity, associated with emotional response and cognitive processes, are involved in moral judgment. Moreover, while it is well-known that responses to the same moral dilemmas differ across individuals, to what extent this variability may be rooted in genetics still remains to be understood. As dopamine is a key modulator of neural processes underlying executive functions, we questioned whether genetic polymorphisms associated with decision-making and dopaminergic neurotransmission modulation would contribute to the observed variability in moral judgment. To this aim, we genotyped five genetic variants of the dopaminergic pathway [rs1800955 in the dopamine receptor D4 (DRD4) gene, DRD4 48 bp variable number of tandem repeat (VNTR), solute carrier family 6 member 3 (SLC6A3) 40 bp VNTR, rs4680 in the catechol-O-methyl transferase (COMT) gene, and rs1800497 in the ankyrin repeat and kinase domain containing 1 (ANKK1) gene] in 200 subjects, who were requested to answer 56 moral dilemmas. As these variants are all located in genes belonging to the dopaminergic pathway, they were combined in multilocus genetic profiles for the association analysis. While no individual variant showed any significant effects on moral dilemma responses, the multilocus genetic profile analysis revealed a significant gender-specific influence on human moral acceptability. Specifically, those genotype combinations that improve dopaminergic signaling selectively increased moral acceptability in females, by making their responses to moral dilemmas more similar to those provided by males. As females usually give more emotionally-based answers and engage the "emotional brain" more than males, our results, though preliminary and therefore in need of replication in independent samples, suggest that this increase in dopamine availability enhances the cognitive and reduces the emotional components of moral decision-making in females, thus favoring a more rationally-driven decision process.Entities:
Keywords: decision-making; dopamine; genetic variant; moral behavior; moral dilemma
Year: 2017 PMID: 28900390 PMCID: PMC5581873 DOI: 10.3389/fnbeh.2017.00156
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
Genotype frequencies and Hardy Weinberg equilibrium statistics for each genetic variant in the whole sample (males plus females) and in the two separate genders.
| rs1800955 | C/C | C/C | 0.120 | 0.125 | 0.245 |
| T-allele | T/C | 0.230 | 0.220 | 0.450 | |
| T/T | 0.155 | 0.150 | 0.305 | ||
| Hardy Weinberg equilibrium | |||||
| non-7r/non-7r | non-7r/non-7r | 0.362 | 0.304 | 0.666 | |
| 7r-allele | 7r/non-7r | 0.122 | 0.152 | 0.274 | |
| 7r/7r | 0.035 | 0.025 | 0.060 | ||
| Hardy Weinberg equilibrium | |||||
| 9r-allele | 9r/9r | 0.055 | 0.050 | 0.105 | |
| 9r/10r | 0.261 | 0.271 | 0.532 | ||
| 10r/10r | 10r/10r | 0.201 | 0.162 | 0.363 | |
| Hardy Weinberg equilibrium | |||||
| A-allele | A/A | 0.116 | 0.111 | 0.227 | |
| G/A | 0.241 | 0.251 | 0.492 | ||
| G/G | G/G | 0.151 | 0.130 | 0.281 | |
| Hardy Weinberg equilibrium | |||||
| A2/A2 (C/C) | A2/A2 (C/C) | 0.345 | 0.380 | 0.725 | |
| A1-allele (T-allele) | A1/A2 (T/C) | 0.150 | 0.105 | 0.255 | |
| A1/A1 (T/T) | 0.015 | 0.005 | 0.020 | ||
| Hardy Weinberg equilibrium |
r = repeats.
Demographic and descriptive data of response variables to moral dilemmas, in the whole sample (males plus females) and in the two separate genders (as reported in Rota et al., 2016).
| Sample size | N | 200 | 102 | 98 |
| Age | mean | 23.06 | 23.46 | 22.64 |
| SD | 6.57 | 7.93 | 4.79 | |
| Freq_Y | mean | 0.48 | 0.42 | 0.54 |
| SD | 0.37 | 0.21 | 0.23 | |
| Acceptability | mean | 2.62 | 2.18 | 3.08 |
| SD | 1.59 | 1.27 | 1.37 | |
| (sqrt)RT_Y | mean | 99.62 | 98.69 | 101.65 |
| SD | 18.99 | 17.03 | 13.96 | |
| (sqrt)RT_N | mean | 97.62 | 94.71 | 101.25 |
| SD | 24.68 | 18.35 | 17.19 | |
| Valence | mean | 3.04 | 2.74 | 3.38 |
| SD | 1.27 | 0.88 | 1.14 | |
| Arousal | mean | 5.04 | 4.99 | 5.09 |
| SD | 1.98 | 1.93 | 1.86 | |
0.01 <
p-value ≤ 0.05;
p-value ≤ 0.001.
Data are means ± SD. Significant p-values are highlighted in gray shade.
Scores assigned to each variant genotype (1 = high activity; 0 = low activity), according to the indicated references, to create the multilocus genetic profiles.
| rs1800955 | C/C | 1 | Okuyama et al., |
| T/C | 0 | ||
| T/T | 0 | ||
| non-7r/non-7r | 1 | Asghari et al., | |
| 7r/non-7r | 0 | ||
| 7r/7r | 0 | ||
| 9r/9r | 1 | Heinz et al., | |
| 9r/10r | 1 | ||
| 10r/10r | 0 | ||
| rs4680 | A/A | 1 | Egan et al., |
| G/A | 1 | ||
| G/G | 0 | ||
| rs1800497 | A2/A2 (C/C) | 1 | Pohjalainen et al., |
| A1/A2 (T/C) | 0 | ||
| A1/A1 (T/T) | 0 |
Figure 1Association results between the dopaminergic Multilocus score and Freq_Y (A), Acceptability (B), (sqrt)RT_Y (C), (sqrt)RT_N (D), Valence (E), and Arousal (F) in the two genders. Bars represent mean ± SEM. 0.01 < *p-value ≤ 0.05.
Figure 2Association results between the dopaminergic dichotomic Multilocus variable and Freq_Y (A), Acceptability (B), (sqrt)RT_Y (C), (sqrt)RT_N (D), Valence (E), and Arousal (F) in the two genders. Bars represent mean ± SEM. 0.01 < *p-value ≤ 0.05.